The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•30 March 2026•

1 min read

Sight Sciences Wins $34 Million Patent Ruling Against Alcon

Key Facts

1The court preserved the jury's finding of willful patent infringement by Alcon.

2Sight Sciences was awarded past damages exceeding $34 million.

3Alcon is required to pay ongoing royalties to Sight Sciences through November 2028.

Sight Sciences (SGHT) has secured a significant legal victory as a court upheld a jury's finding of willful patent infringement by Alcon. The ruling pertains to Alcon's Hydrus Microstent, which was found to violate Sight Sciences' intellectual property rights. As part of the judgment, Sight Sciences was awarded more than $34 million in past damages. Furthermore, the court ordered Alcon to pay ongoing royalties to the company through November 2028. This decision follows a series of post-trial motions that ultimately favored the medical device manufacturer. The outcome provides a substantial financial boost for Sight Sciences while confirming a significant liability for Alcon.

Create Free Account

Version History

1 additional source confirmed this story